ANDERMAN JONATHAN (Sr VP, Gen Counsel & Corp Sec) purchased 2000.0% of their position (20K shares) of COMPASS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $30.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/8/2025ACC: 0001171843-25-002086
Officer· Sr VP, Gen Counsel & Corp Sec
Since Aug 2024
+20K
Net shares
Net buyer
$30.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$1.54
Trade value
$30.80K
% of position
2000.0%
4/7/2025
1K→21K
Total
Net shares
+20K
Net value
$30.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/7/2025 | P · Purchase | +20K | $1.54 | $30.80K | 2000.0% | 1K | 21K |
| Total | +20K | $30.80K | ||||||
Derivative Transactions0
No derivative transactions reported